Endocrine Society RPHR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Right arrow Return to article

TABLE I Degree of Whole-body Aromatase Inhibition by Drugs Used in Breast Cancer Clinical Efficacy

Drug Dose Mean percentage inhibition Reference

Aminoglutethimide (+ hydrocortisone) 1000 mg (+ 40 mg)/d 90.6 MacNeill et al., 1992
Formestane 250 mg/2 w (im) 84.8 Jones et al., 1992
Fadrozole 2 mg/d 82.4 Lonning et al., 1991
Vorozole 1 mg/d 93.0 Van der Wall et al., 1993
Letrozole 2.5 mg/d > 99.1 Geisler et al., 2001
Anastrozole 1 mg/d 97.3 Geisler et al., 2001
Exemestane 25 mg/d 97.9 Geisler et al., 1998

[All analyses, other than Van der Wall et al. (1993) were conducted in the Dowsett laboratory.]





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals